Clinical Research Directory
Browse clinical research sites, groups, and studies.
PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
Sponsor: Ruijin Hospital
Summary
This study intends to evaluate the application value of Positron Emission Tomography/Magnetic Resonance (PET/MR) in the staging and efficacy evaluation of NK/T cell lymphoma, aiming to explore a more accurate system for predicting the prognosis of patients and guiding the treatment.
Official title: PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma: a Prospective, Single-arm Clinical Study
Key Details
Gender
All
Age Range
14 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2023-05-26
Completion Date
2026-10
Last Updated
2024-10-26
Healthy Volunteers
No
Conditions
Interventions
Positron Emission Tomography/Magnetic Resonance (PET/MR)
18F-FDG PET/MR imaging (manufacturer: Siemens, model: Biography mMR). Research devices are marketed products.
Locations (1)
Ruijin Hospital
Shanghai, Shanghai Municipality, China